Product logins

Find logins to all Clarivate products below.


Non-Alcoholic Steatohepatitis (NASH) | Unmet Need | US/EU | 2017

NASH has the potential to be a large and lucrative therapy market owing to the prevalence of the disease and the lack of approved agents. Patients with NASH are at risk of liver fibrosis, cardiovascular disease, and cancer. Currently, physicians are limited to off-label therapies that have limited evidence to support prescribing. Consequently, there is a pressing need for new, effective drug treatments. In this report, hepatologists reveal what attributes drive their prescribing and what they are looking for in terms of efficacy, safety, and delivery from future treatments. Using the Target Product Profile (TPP) simulator, we can establish physicians’ preference for emerging drugs and assess if these drugs can capitalize on the untapped NASH space.

Related Market Assessment Reports

Report
Squamous Cell Carcinoma of the Head and Neck – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most commonly diagnosed cancer. It encompasses a spectrum of heterogeneous tumors originating at multiple sites in the head and…
Report
Bispecific Therapies – Access & Reimbursement – Access & Reimbursement – Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma (US)
Bispecific therapies provide a valuable treatment option in hematological cancers, offering an “off-the-shelf” option for oncologists to treat patients with B-cell Non-Hodgkin’s lymphoma or…
Report
Myelofibrosis – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Myelofibrosis is a hematological malignancy characterized by disrupted blood cell production and bone marrow scarring. Symptoms include severe anemia, weakness, fatigue, and splenomegaly. The only…
Report
Hypertension – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
Resistant hypertension (RHTN) is defined as blood pressure that remains above target despite concurrent treatment with three optimally dosed conventional antihypertensives and is independently…
Report
Alopecia – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Alopecia areata (AA) is an inflammatory autoimmune skin disease characterized by varying degrees of hair loss. The immune system mistakenly targets anagen hair follicles. While topical…